3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Phase 2
1
Status
Recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Carcinoma, Non-Small-Cell Lung
150
Lung Neoplasms
58
Pancreatic Neoplasms
34
Neoplasms
20
Neoplasm Metastasis
15
Breast Neoplasms
15
Adenocarcinoma of Lung
15
Brain Neoplasms
14
Adenocarcinoma, Bronchiolo-Alveolar
13
Glioblastoma
12
Non-Squamous Non-Small Cell Lung Cancer
11
Head and Neck Neoplasms
11
Gliosarcoma
11
Squamous Cell Carcinoma of Head and Neck
10
Carcinoma, Hepatocellular
10
Colorectal Neoplasms
8
Carcinoma, Renal Cell
8
Esophageal Neoplasms
6
Urinary Bladder Neoplasms
5
Gallbladder Neoplasms
5
Colonic Neoplasms
5
Central Nervous System Neoplasms
5
Carcinoma, Squamous Cell
5
Adenocarcinoma
5
Rectal Neoplasms
4
Prostatic Neoplasms
4
Ovarian Neoplasms
4
Liver Neoplasms
4
Kidney Neoplasms
4
Fallopian Tube Neoplasms
4
Interventions
Dexamethasone
338
Bortezomib
188
Lenalidomide
186
Cyclophosphamide
166
Melphalan
124
Calcium Dobesilate
108
daratumumab
95
fludarabine phosphate
69
carfilzomib
69
pomalidomide
68
Peripheral Blood Stem Cell Transplantation
64
Filgrastim
56
Thalidomide
55
Busulfan
53
Mycophenolic Acid
52
Tacrolimus
45
Granulocyte Colony-Stimulating Factor
45
ixazomib
43
fludarabine
42
Whole-Body Irradiation
40
Cyclosporine
35
Etoposide
33
dexamethasone acetate
31
Antilymphocyte Serum
31
isatuximab
29
dexamethasone 21-phosphate
26
Prednisone
26
elotuzumab
25
Biopsy
25
auricularum
24
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Multiple Myeloma
×
Erlotinib Hydrochloride
×
Clear all
NCT03297606
2026-03-27
CAPTUR
Canadian Cancer Trials Group
Phase 2
Recruiting
720 enrolled